Eating disorders can strike anyone, at any weight, at any age
Each year, on June 2nd, the world pauses to reckon with illnesses that hide in plain sight — eating disorders that claim lives not because they are untreatable, but because they go unseen for too long. Brazil's Society of Endocrinology and Metabolism joined more than 200 organizations across 50 countries in 2026 to affirm a difficult truth: stigma, more than biology, is often what delays the care that saves lives. In a moment when new weight-loss medications are reshaping clinical practice, the call for vigilance, compassion, and early recognition has never been more urgent.
- Eating disorders remain dangerously misread — the assumption that only visibly thin patients are at risk leaves countless people undiagnosed while their condition quietly deepens.
- The endocrine system pays a steep price: hormonal collapse, bone loss, thyroid disruption, and metabolic crisis can all unfold before a diagnosis is ever made.
- A new clinical blind spot has emerged — GLP-1 agonists prescribed for obesity can mask atypical anorexia in vulnerable patients, as intended weight loss conceals disordered eating beneath a veneer of medical success.
- No single specialist can navigate this terrain alone; recovery depends on endocrinologists, psychiatrists, psychologists, and nutritionists working in coordinated, judgment-free concert.
- The trajectory points toward integration — multiprofessional, stigma-free care is not aspirational language but the evidence-based standard that measurably improves survival and quality of life.
On June 2nd, the Brazilian Society of Endocrinology and Metabolism joined a global campaign spanning more than 200 organizations in 50 countries to mark World Eating Disorders Action Day. The campaign's message was both simple and urgent: these conditions are treatable, but stigma stands between patients and the care they need.
Endocrinologist Dr. Priscilla Gil points to one of the field's most persistent and harmful myths — that eating disorders only affect visibly emaciated individuals. In reality, patients who restrict food intake, fear weight gain, and suffer serious physical consequences often present at normal or above-normal weight, going undiagnosed until the disorder has taken firm hold. Eating disorders cross every demographic boundary: any age, any gender, any body type. Genetic predisposition, high-pressure environments like competitive sports or modeling, and the image-saturated world of social media all create vulnerability. Recognizing warning signs early — before patterns solidify into anorexia, bulimia, binge eating disorder, or avoidant restrictive food intake disorder — dramatically improves recovery outcomes.
The physical toll is severe and measurable. Eating disorders disrupt hormonal function, suppress menstruation, erode bone density, and trigger thyroid dysfunction. They are not only psychiatric conditions — they are medical emergencies with real physiological consequences that demand coordinated care from endocrinologists, psychiatrists, psychologists, and nutritionists working together in a judgment-free environment.
A specific alert now faces clinicians prescribing GLP-1 receptor agonists for obesity. While these medications produce effective weight loss, they can obscure the emergence of atypical anorexia nervosa in vulnerable patients — those with a personal or family history of disordered eating — where severe restriction and intense fear of weight gain persist even as the scale moves in the expected direction. Systematic monitoring of eating behaviors, body image, and psychiatric symptoms throughout treatment is not optional; it is the only reliable safeguard against serious harm.
On June 2nd, the Brazilian Society of Endocrinology and Metabolism joined a global mobilization to mark World Eating Disorders Action Day—a coordinated effort spanning more than 200 organizations across 50 countries. The campaign's central message was straightforward but urgent: eating disorders are treatable conditions, stigma delays diagnosis, and early detection saves lives.
The timing of this year's emphasis on evidence-based information and stigma reduction reflects a persistent problem in clinical practice. Dr. Priscilla Gil, an endocrinologist specializing in eating disorders and member of the Academy for Eating Disorders, identifies one of the field's most damaging misconceptions: the belief that eating disorders only affect visibly emaciated people. This narrow understanding causes real harm. Patients who maintain normal or above-normal weight while restricting food intake, experiencing intense fear of weight gain, and suffering the physical and psychological consequences of an eating disorder often go undiagnosed until their condition has progressed significantly. The disorder does not announce itself through appearance alone.
Eating disorders strike across all demographics—any age, any gender, any body type. Genetic predisposition matters. So do environmental factors: competitive sports that demand low body weight, ballet, modeling, and the relentless image-focused culture of social media influencing all create vulnerability. But the disorder can emerge in someone whose weight appears entirely appropriate for their height and age. This is why early recognition of warning signs—disordered eating behaviors, distorted body image perception, rapid weight changes—becomes the critical intervention point. Catching these patterns before they crystallize into full anorexia nervosa, bulimia nervosa, binge eating disorder, or avoidant restrictive food intake disorder dramatically improves the chances of recovery.
The endocrine system bears particular damage from these conditions. Eating disorders disrupt hormonal function, suppress menstruation, erode bone mineral density, trigger thyroid dysfunction, and create cascading metabolic complications rooted in malnutrition and disordered eating behavior. These are not merely psychiatric illnesses—they are medical emergencies with measurable physiological consequences.
Dr. Gil emphasizes that early diagnosis enables more effective intervention and reduces the risk of clinical, metabolic, and psychiatric complications. But diagnosis requires a specific clinical posture: treatment must be judgment-free, welcoming, and multiprofessional. A single doctor cannot manage an eating disorder alone. The condition demands coordination among endocrinologists, psychiatrists, psychologists, nutritionists, and other specialists working in concert. This integrated approach significantly increases recovery rates and improves quality of life.
A particular alert now faces endocrinologists prescribing GLP-1 receptor agonists for obesity treatment. These medications produce rapid weight loss, which is their intended effect. But in vulnerable patients—those with genetic predisposition, personal or family history of eating disorders, or existing disordered eating patterns—rapid weight loss can mask the emergence or worsening of atypical anorexia nervosa. In this condition, the patient severely restricts food intake and experiences intense fear of weight gain with all the physical and psychological hallmarks of anorexia, yet maintains weight within or above the normal range. The medication's effectiveness at producing weight loss can obscure the underlying disorder, making systematic monitoring essential. Endocrinologists must assess eating behaviors, body image perception, and psychiatric symptoms throughout treatment, especially in high-risk patients. Early recognition and multiprofessional intervention remain the only reliable path to preventing serious harm.
Notable Quotes
Eating disorders can affect people of any sex, age, and body weight, influenced by genetic factors, individual characteristics, and environmental vulnerability—including sports, dance, modeling, and social media culture that emphasize low body weight and appearance.— Dr. Priscilla Gil, endocrinologist and Academy for Eating Disorders member
Early diagnosis allows for more effective intervention and reduces the risk of clinical, metabolic, and psychiatric complications. Treatment must be judgment-free, welcoming, and multiprofessional to significantly increase recovery chances and improve quality of life.— Dr. Priscilla Gil
The Hearth Conversation Another angle on the story
Why does it matter that eating disorders affect people at normal weights? Doesn't the damage show up eventually anyway?
The damage is already happening—hormonal disruption, bone loss, metabolic stress. But a person at normal weight often doesn't trigger alarm in others or in themselves. They think they're fine because the scale says so. By the time anyone notices, years may have passed.
So stigma isn't just about judgment—it's about invisibility.
Exactly. The stereotype of the skeletal patient means we miss the person who eats 400 calories a day but weighs 140 pounds. The disorder progresses in silence.
You mentioned GLP-1 drugs as a new concern. How does that work?
A doctor prescribes it for weight loss. The patient loses weight rapidly—that's the goal. But if they're vulnerable to eating disorders, the medication can enable restriction without anyone noticing. The weight loss looks like success. The disordered eating hides inside it.
So the treatment itself becomes a risk factor.
In the wrong patient, yes. Which is why endocrinologists now need to screen for eating disorder risk before prescribing, and monitor behavior throughout treatment, not just weight.
What does recovery actually look like?
It requires a team—psychiatrist, psychologist, nutritionist, endocrinologist—all working together without judgment. When that happens, people do recover. Quality of life improves. But it only works if the disorder is caught early enough to intervene.